Skip to main content

Table 1 Clinicopathological characteristic of 412 patients with BCa from TCGA database

From: Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis

Clinicopathological characteristics Value
Age, years
 Mean ± SD 68.09 ± 10.58
 Range 34–90
Gender, n (%)
 Female 108 (26.2)
 Male 304 (73.8)
Grade, n (%)
 High 388 (94.1)
 Low 21 (5.1)
 Unknown 3 (0.8)
TCGA stage
 Stage I 2 (0.5)
 Stage II 131 (31.8)
 Stage III 141 (34.2)
 Stage IV 136 (33.0)
 Unknown 2 (0.5)
T stage, n (%)
 T0 1 (0.2)
 T1 3 (0.7)
 T2 120 (29.1)
 T3 196 (47.6)
 T4 59 (14.3)
 Unknown 33 (8.1)
N stage, n (%)
 N0 239 (58.1)
 N1 47 (11.4)
 N2 76 (18.4)
 N3 8 (1.9)
 Unknown 42 (10.2)
M stage, n (%)
 M0 196 (47.5)
 M1 11 (2.7)
 Unknown 205 (49.8)